Bio-Site Receives $49.8 Million Cornerstone Investment
Biositu is a high-tech company based on a stable and efficient gene editing technology platform, which integrates model animal customization services, important model animal development and large-scale reproduction and supply, in vivo pharmacology and efficacy evaluation services, and antibody drug R&D outsourcing services. Biopharmaceutical companies. It has a gene editing platform, a model animal reproduction […]
Bio-Site Receives $49.8 Million Cornerstone Investment Read More »